These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3486365)

  • 1. Methotrexate therapy and nitrous oxide anesthesia.
    Ueland PM; Refsum H; Wesenberg F; Kvinnsland S
    N Engl J Med; 1986 Jun; 314(23):1514. PubMed ID: 3486365
    [No Abstract]   [Full Text] [Related]  

  • 2. High-dose methotrexate with citrovorum factor rescue: predictive value of serum methotrexate concentrations and corrective measures to avert toxicity.
    Nirenberg A; Mosende C; Mehta BM; Gisolfi AL; Rosen G
    Cancer Treat Rep; 1977 Aug; 61(5):779-83. PubMed ID: 302143
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials and pharmacokinetics of intermittent high-dose methotrexate-"leucovorin rescue" for children with malignant tumors.
    Pratt CB; Roberts D; Shanks EC; Warmath EL
    Cancer Res; 1974 Dec; 34(12):3326-31. PubMed ID: 4547680
    [No Abstract]   [Full Text] [Related]  

  • 4. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
    Djerassi I; Kim JS; Shulman K
    Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
    [No Abstract]   [Full Text] [Related]  

  • 5. Recovery from toxicity associated with high-dose methotrexate: prognostic factors.
    Chan H; Evans WE; Pratt CB
    Cancer Treat Rep; 1977 Aug; 61(5):797-804. PubMed ID: 19151
    [No Abstract]   [Full Text] [Related]  

  • 6. Methotrexate/nitrous-oxide toxic interaction in perioperative chemotherapy for early breast cancer.
    Goldhirsch A; Gelber RD; Tattersall MN; Rudenstam CM; Cavalli F
    Lancet; 1987 Jul; 2(8551):151. PubMed ID: 2885607
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose methotrexate with folinic acid rescue.
    Bender JF; Grove WR; Fortner CL
    Am J Hosp Pharm; 1977 Sep; 34(9):961-5. PubMed ID: 333910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-neoplastic synergism of nitrous oxide and methotrexate.
    Gillman MA
    Br J Anaesth; 1988 Feb; 60(3):349-50. PubMed ID: 3348931
    [No Abstract]   [Full Text] [Related]  

  • 9. A clinical and pharmacological study of high-dose methotrexate with minimal leucovorin rescue.
    Stoller RG; Kaplan HG; Cummings FJ; Calabresi P
    Cancer Res; 1979 Mar; 39(3):908-12. PubMed ID: 311683
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and pharmacological studies of methotrexate-minimal leucovorin rescue plus fluorouracil.
    Wiemann MC; Cummings FJ; Kaplan HG; Spremulli EN; Doolittle CH; Calabresi P
    Cancer Res; 1982 Sep; 42(9):3896-900. PubMed ID: 6980707
    [No Abstract]   [Full Text] [Related]  

  • 11. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
    Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
    Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
    Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.
    Von Hoff DD; Penta JS; Helman LJ; Slavik M
    Cancer Treat Rep; 1977 Jul; 61(4):745-8. PubMed ID: 301783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case of anesthesia convulsions under nitrous oxide-halothane anesthesia].
    Krenn J; Porges P; Steinbereithner K
    Anaesthesist; 1967 Mar; 16(3):83-5. PubMed ID: 5586283
    [No Abstract]   [Full Text] [Related]  

  • 15. Tympanic membrane rupture following general anesthesia with nitrous oxide: a case report.
    Ohryn M
    AANA J; 1995 Feb; 63(1):42-4. PubMed ID: 7762371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions may be important risk factors for methotrexate neurotoxicity, particularly in pediatric leukemia patients.
    Forster VJ; van Delft FW; Baird SF; Mair S; Skinner R; Halsey C
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):1093-1096. PubMed ID: 27659182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should nitrous oxide ever be used in oncology patients receiving methotrexate therapy?
    Forster VJ; Bell G; Halsey C
    Paediatr Anaesth; 2020 Jan; 30(1):9-16. PubMed ID: 31667903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Single"-agent activity of high-dose methotrexate with citrovorum factor rescue.
    Von Hoff DD; Rozencweig M; Louie AC; Bender RA; Muggia FM
    Cancer Treat Rep; 1978 Feb; 62(2):233-5. PubMed ID: 305823
    [No Abstract]   [Full Text] [Related]  

  • 19. High-dose methotrexate with leucovorin rescue.
    Akahoshi M
    Cancer Nurs; 1978 Aug; 1(4):319-25. PubMed ID: 307982
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of malignant neoplasms in advanced stages with HDMTX-CF Rescue (high-dose methotrexate-citrovorum factor rescue)].
    Paparopoli G; Agostara B; Di Girolamo G
    Clin Ter; 1981 May; 97(3):271-81. PubMed ID: 6974631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.